CXCL10 and sarcoma: Beyond the eye, CXCL10 is well known for reducing angiogenesis in sarcoma,50 after spinal cord injury,51 or in the heart,52 suggesting that CXCL10 could be a noteworthy candidate for further research concerning vasoproliferative eye diseases.